Prospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7832-7843
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7832
Table 1 Sociodemographic and clinical features of participants
Sociodemographic features n (%)
SexFemale89 (51.7)
Male83 (48.3)
Age (yr)18-5072 (41.9)
50-86100 (58.1)
Marital statusMarried 137 (79.7)
Single 13 (7.6)
Divorced 7 (4.1)
Widowed15 (8.7)
HouseholdFamily137 (79.7)
Roommate3 (1.7)
Partner23 (13.4)
Alone9 (5.2)
ChildrenNo17 (9.9)
Yes155 (90.1)
EmploymentEmployed52 (30.2)
Unemployed4 (2.3)
Retired40 (23.3)
Housewife71 (41.3)
Other5 (2.9)
Financial statusLow income73 (42.4)
Middle income82 (47.7)
High income17 (9.9)
Smoking historyYes29 (16.9)
No143 (83.1)
AlcoholYes6 (3.5)
No166 (96.5)
Clinical features
Chronic diseaseNo comorbidity85 (49.4)
Hypertension10 (5.8)
Diabetes8 (4.7)
Cardiovascular6 (3.5)
Cancer3 (1.7)
Pulmonary13 (7.6)
Neurologic3 (1.7)
Gastrointestinal1 (0.6)
Thyroid1 (0.6)
Allergic2 (1.2)
Rheumatologic1 (0.6)
Endocrinology1 (0.6)
Metabolic1 (0.6)
Other infections1 (0.6)
Fibromyalgia1 (0.6)
2 medical diseases, one from first 516 (9.3)
2 medical diseases, two from the first 52 (1.2)
2 or more of first 517 (9.9)
Psychiatric comorbidityYes46 (26.7)
No126 (73.3)
ReinfectionYes32 (18.6)
No140 (81.4)
VaccinationYes153 (89)
No19 (11)
Which vaccineNone17 (9.9)
2 Sinovac22 (12.9)
3 Sinovac33 (19.3)
2 BioNTech55 (32.2)
2 Sinovac+1 BioNTech36 (21.1)
2 Sinovac+2 BioNTech3 (1.8)
1 BioNTech4 (2.3)
1 Sinovac1 (0.6)
Death of relatives caused by COVID-19Yes51 (29.7)
No121 (70.3)
Persistent symptomsYes83 (48.3)
No89 (51.7)
Tiredness67 (39)
Palpitation30 (17.4)
Dyspnea30 (17.4)
Sleep disorders5 (2.9)
Easy fatigue5 (2.9)
Other symptoms9 (5.2)